Suitors Weigh Bids for Sanofi's $3B European Generics Biz Post author:Sam Post published:January 10, 2018 Post category:BioPharma The portfolio consists of acute, chronic and oncology products. Source: BioSpace You Might Also Like Athenex, A US-China Cancer Company, Stages $66 Million U.S. IPO June 15, 2017 Boston's Paratek Heads to The Auction Block August 22, 2017 <b>Ann Romney</b> Opens Day Three Of The BIO International Convention With A Keynote Session June 21, 2017
<b>Ann Romney</b> Opens Day Three Of The BIO International Convention With A Keynote Session June 21, 2017
